Quantcast
Environmental News for a Healthier Planet and Life

Help Support EcoWatch

When Will There Be a Coronavirus Vaccine? 5 Questions Answered

Health + Wellness
When Will There Be a Coronavirus Vaccine? 5 Questions Answered
The Director of the Chinese Center for Disease Control and Prevention, Gao Fu speaks on Jan. 26 during a press briefing on studying the 2019-nCoV coronavirus and developing a vaccine to prevent it. Roman Balandin / TASS / Getty Images

Editor's note: The coronavirus that started in Wuhan has sickened more than 4,000 people and killed at least 100 in China as of Jan. 27, 2020. Thailand and Hong Kong each have reported eight confirmed cases, and five people in the U.S. have been diagnosed with the illness. People are hoping for a vaccine to slow the spread of the disease.


Is there a vaccine under development for the coronavirus?

Work has begun at multiple organizations, including the National Institutes of Health, to develop a vaccine for this new strain of coronavirus, known among scientists as 2019-nCoV.

Scientists are just getting started working, but their vaccine development strategy will benefit both from work that has been done on closely related viruses, such as SARS and MERS, as well as advances that have been made in vaccine technologies, such as nucleic acid vaccines, which are DNA- and RNA-based vaccines that produce the vaccine antigen in your own body.

Was work underway on this particular strain?

No, but work was ongoing for other closely related coronaviruses that have caused severe disease in humans, namely MERS and SARS. Scientists had not been concerned about this particular strain, as we did not know that it existed and could cause disease in humans until it started causing this outbreak.

How do scientists know when to work on a vaccine for a coronavirus?

Work on vaccines for severe coronaviruses has historically begun once the viruses start infecting humans.

Given that this is the third major outbreak of a new coronavirus that we have had in the past two decades and also given the severity of disease caused by these viruses, we should consider investing in the development of a vaccine that would be broadly protective against these viruses.

What does this work involve, and when might we actually have a vaccine?

This work involves designing the vaccine constructs – for example, producing the right target antigens, viral proteins that are targeted by the immune system, followed by testing in animal models to show that they are protective and safe.

Once safety and efficacy are established, vaccines can advance into clinical trials in humans. If the vaccines induce the expected immune response and protection and are found safe, they can be mass produced for vaccination of the population.

Currently, we lack virus isolates – or samples of the virus – to test the vaccines against. We also lack antibodies to make sure the vaccine is in good shape. We need the virus in order to test if the immune response induced by the vaccine works. Also, we need to establish what animals to test the vaccine on. That potentially could include mice and nonhuman primates.

Vaccine development will likely take months.

Can humans ever be safe from these types of outbreaks?

We expect that these types of outbreaks will occur for the foreseeable future in irregular intervals.

To try to prevent large outbreaks and pandemics, we need to improve surveillance in both humans and animals worldwide as well as invest in risk assessment, allowing scientists to evaluate the potential threat to human health from the virus, for detected viruses.

We believe that global action is needed to invest in novel vaccine approaches that can be employed quickly whenever a new virus like the current coronavirus – and also viruses similar to Zika, Ebola or influenza – emerges. Currently, responses to emerging pathogens are mostly reactive, meaning they start after the outbreak happens. We need a more proactive approach supported by continuous funding.

Reposted with permission from The Conversation.

Colette Pichon Battle, attorney, founder, and executive director of the Gulf Coast Center for Law & Policy. Colette Pichon Battle

By Karen L. Smith-Janssen

Colette Pichon Battle gave a December 2019 TEDWomen Talk on the stark realities of climate change displacement, and people took notice. The video racked up a million views in about two weeks. The attorney, founder, and executive director of the Gulf Coast Center for Law & Policy (GCCLP) advocates for climate justice in communities of color. Confronted with evidence showing how her own South Louisiana coastal home of Bayou Liberty will be lost to flooding in coming years, the 2019 Obama Fellow dedicates herself to helping others still reeling from the impacts of Katrina face the heavy toll that climate change has taken—and will take—on their lives and homelands. Her work focuses on strengthening multiracial coalitions, advocating for federal, state, and local disaster mitigation measures, and redirecting resources toward Black communities across the Gulf South.

Read More Show Less

EcoWatch Daily Newsletter

A palm tree plantation in Malaysia. Yann Arthus-Bertrand / Getty Images Plus

Between 2000 and 2013, Earth lost an area of undisturbed ecosystems roughly the size of Mexico.

Read More Show Less

Trending

A home burns during the Bobcat Fire in Juniper Hills, California on September 18, 2020. Kyle Grillot / AFP/ Getty Images

By Stuart Braun

"These are not just wildfires, they are climate fires," Jay Inslee, Governor of Washington State, said as he stood amid the charred remains of the town of Malden west of Seattle earlier this month. "This is not an act of God," he added. "This has happened because we have changed the climate of the state of Washington in dramatic ways."

Read More Show Less
A new report from Oxfam found that the wealthiest one percent of the world produced a carbon footprint that was more than double that of the bottom 50 percent of the world. PickPik

A new report from Oxfam found that the wealthiest one percent of the world produced a carbon footprint that was more than double that of the bottom 50 percent of the world, The Guardian reported. The study examined 25 years of carbon dioxide emissions and wealth inequality from 1990 to 2015.

Read More Show Less
The label of one of the recalled thyroid medications. FDA

If you are taking medication for an underactive thyroid, check your prescription.

Read More Show Less

Support Ecowatch